Use and misuse of the receiver operating characteristic curve in risk prediction

被引:1640
作者
Cook, Nancy R.
机构
[1] Harvard Univ, Div Prevent Med, Dept Med, Brigham & Womens Hosp,Sch Med, Boston, MA 02215 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
关键词
cardiovascular diseases; epidemiology; follow-up studies; prevention; risk factors; statistics; risk;
D O I
10.1161/CIRCULATIONAHA.106.672402
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The c statistic, or area under the receiver operating characteristic ( ROC) curve, achieved popularity in diagnostic testing, in which the test characteristics of sensitivity and specificity are relevant to discriminating diseased versus nondiseased patients. The c statistic, however, may not be optimal in assessing models that predict future risk or stratify individuals into risk categories. In this setting, calibration is as important to the accurate assessment of risk. For example, a biomarker with an odds ratio of 3 may have little effect on the c statistic, yet an increased level could shift estimated 10- year cardiovascular risk for an individual patient from 8% to 24%, which would lead to different treatment recommendations under current Adult Treatment Panel III guidelines. Accepted risk factors such as lipids, hypertension, and smoking have only marginal impact on the c statistic individually yet lead to more accurate reclassification of large proportions of patients into higher- risk or lower- risk categories. Perfectly calibrated models for complex disease can, in fact, only achieve values for the c statistic well below the theoretical maximum of 1. Use of the c statistic for model selection could thus naively eliminate established risk factors from cardiovascular risk prediction scores. As novel risk factors are discovered, sole reliance on the c statistic to evaluate their utility as risk predictors thus seems ill-advised.
引用
收藏
页码:928 / 935
页数:8
相关论文
共 37 条
  • [1] [Anonymous], 1997, P BIOMETRICS SECTION
  • [2] Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) study
    Blankenberg, Stefan
    McQueen, Matthew J.
    Smieja, Marek
    Pogue, Janice
    Balion, Cynthia
    Lonn, Eva
    Rupprecht, Hans J.
    Bickel, Christoph
    Tiret, Laurence
    Cambien, Francois
    Gerstein, Hertzel
    Muenzel, Thomas
    Yusuf, Salim
    [J]. CIRCULATION, 2006, 114 (03) : 201 - 208
  • [3] Brenner H, 1997, STAT MED, V16, P981, DOI 10.1002/(SICI)1097-0258(19970515)16:9<981::AID-SIM510>3.0.CO
  • [4] 2-N
  • [5] CARROLL M, 1993, VITAL HLTH STAT, V242, P1
  • [6] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [7] The effect of including C-reactive protein in cardiovascular risk prediction models for women
    Cook, Nancy R.
    Buring, Julie E.
    Ridker, Paul M.
    [J]. ANNALS OF INTERNAL MEDICINE, 2006, 145 (01) : 21 - 29
  • [8] The latest and greatest new biomarkers - Which ones should we measure for risk prediction in our practice?
    de Lemos, James A.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (22) : 2428 - 2430
  • [9] WHAT PRICE PERFECTION - CALIBRATION AND DISCRIMINATION OF CLINICAL-PREDICTION MODELS
    DIAMOND, GA
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (01) : 85 - 89
  • [10] DRIZD T, 1986, VITAL HLTH STAT, V234, P1